Kyoko Watanabe

Kyoko Watanabe

Auto-generated profile, based on publicly available information

Kyoko Watanabe

Regeneron Genetics Center, Tarrytown, USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
KWKyoko Watanabe
Kyoko Watanabe
ETErdogan Taskesen
Erdogan Taskesen
ABArjen van Bochoven
Arjen van Bochoven
DPDanielle Posthuma
Danielle Posthuma
A main challenge in genome-wide association studies (GWAS) is to pinpoint possible causal variants. Results from GWAS typically do not directly translate into causal variants because the majority of hits are in non-coding or intergenic regions, and the presence of linkage disequilibrium leads to effects being statistically spread out across multiple variants. Post-GWAS annotation facilitates the selection of most likely causal variant(s). Multiple resources are available for post-GWAS annotation, yet these can be time consuming and do not provide integrated visual aids for data interpretation. We, therefore, develop FUMA: an integrative web-based platform using information from multiple biological resources to facilitate functional annotation of GWAS results, gene prioritization and interactive visualization. FUMA accommodates positional, expression quantitative trait loci (eQTL) and chromatin interaction mappings, and provides gene-based, pathway and tissue enrichment results. FUMA results directly aid in generating hypotheses that are testable in functional experiments aimed at proving causal relations.

18 January 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AKAlexander Kurilshikov
Alexander Kurilshikov
CGCarolina Medina Gomez
Carolina Medina Gomez
RBRodrigo Bacigalupe
Rodrigo Bacigalupe
DRDjawad Radjabzadeh
Djawad Radjabzadeh
JWJun Wang
Jun Wang
AZAlexandra Zhernakova
Alexandra Zhernakova

19 August 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
KWKyoko Watanabe
Kyoko Watanabe
SSSven Stringer
Sven Stringer
OFOleksandr Frei
Oleksandr Frei
MMMaša Umićević Mirkov
Maša Umićević Mirkov
CLChristiaan de Leeuw
Christiaan de Leeuw
DPDanielle Posthuma
Danielle Posthuma

25 June 2018 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JSJeanne E. Savage
Jeanne E. Savage
PJPhilip R. Jansen
Philip R. Jansen
SSSven Stringer
Sven Stringer
KWKyoko Watanabe
Kyoko Watanabe
JBJulien Bryois
Julien Bryois
DPDanielle Posthuma
Danielle Posthuma
Intelligence is highly heritable1 and a major determinant of human health and well-being2. Recent genome-wide meta-analyses have identified 24 genomic loci linked to variation in intelligence3,4,5,6,7, but much about its genetic underpinnings remains to be discovered. Here, we present a large-scale genetic association study of intelligence (n = 269,867), identifying 205 associated genomic loci (190 new) and 1,016 genes (939 new) via positional mapping, expression quantitative trait locus (eQTL) mapping, chromatin interaction mapping, and gene-based association analysis. We find enrichment of genetic effects in conserved and coding regions and associations with 146 nonsynonymous exonic variants. Associated genes are strongly expressed in the brain, specifically in striatal medium spiny neurons and hippocampal pyramidal neurons. Gene set analyses implicate pathways related to nervous system development and synaptic structure. We confirm previous strong genetic correlations with multiple health-related outcomes, and Mendelian randomization analysis results suggest protective effects of intelligence for Alzheimer’s disease and ADHD and bidirectional causation with pleiotropic effects for schizophrenia. These results are a major step forward in understanding the neurobiology of cognitive function as well as genetically related neurological and psychiatric disorders.

18 October 2021 in Nature
Verified
Journal Article
Open access
PDF file
JBJoshua D. Backman
Joshua D. Backman
ALAlexander H. Li
Alexander H. Li
AMAnthony Marcketta
Anthony Marcketta
DSDylan Sun
Dylan Sun
JMJoelle Mbatchou
Joelle Mbatchou
MFManuel A. R. Ferreira
Manuel A. R. Ferreira
A major goal in human genetics is to use natural variation to understand the phenotypic consequences of altering each protein-coding gene in the genome. Here we used exome sequencing1 to explore protein-altering variants and their consequences in 454,787 participants in the UK Biobank study2. We identified 12 million coding variants, including around 1 million loss-of-function and around 1.8 million deleterious missense variants. When these were tested for association with 3,994 health-related traits, we found 564 genes with trait associations at P ≤ 2.18 × 10−11. Rare variant associations were enriched in loci from genome-wide association studies (GWAS), but most (91%) were independent of common variant signals. We discovered several risk-increasing associations with traits related to liver disease, eye disease and cancer, among others, as well as risk-lowering associations for hypertension (SLC9A3R2), diabetes (MAP3K15, FAM234A) and asthma (SLC27A3). Six genes were associated with brain imaging phenotypes, including two involved in neural development (GBE1, PLD1). Of the signals available and powered for replication in an independent cohort, 81% were confirmed; furthermore, association signals were generally consistent across individuals of European, Asian and African ancestry. We illustrate the ability of exome sequencing to identify gene–trait associations, elucidate gene function and pinpoint effector genes that underlie GWAS signals at scale.

25 February 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
PJPhilip R. Jansen
Philip R. Jansen
KWKyoko Watanabe
Kyoko Watanabe
SSSven Stringer
Sven Stringer
NSNathan Skene
Nathan Skene
JBJulien Bryois
Julien Bryois
DPDanielle Posthuma
Danielle Posthuma